济川药业23年度暨24年季度业绩交流

Company Overview - The company has a history dating back to 1967, originally established as Taixin Shichenxi Pharmaceutical Factory, marking 57 years of operation [1] - The company entered the top 100 pharmaceutical manufacturers in China in 2004 [1] - The company has been publicly listed for over ten years since its initial public offering in December 2013 [1] Key Points and Arguments - The company is focused on its operational performance and aims to address investor inquiries regarding its business situation [1] Other Important Content - The meeting is part of the company's quarterly performance briefing for Q1 2023 and Q1 2024, indicating a forward-looking approach [1]